Transcription of INFECTIOUS DISEASES LABORATORY TEST DIRECTORY
{{id}} {{{paragraph}}}
Example: marketing
INFECTIOUS DISEASES LABORATORY TEST DIRECTORY
February 2022, Version CDC INFECTIOUS DISEASES LABORATORY TEST DIRECTORY This document was created under National Center for Emerging and Zoonotic DISEASES / Office of INFECTIOUS DISEASES (NCEZID/OD). The printed version of CDC's INFECTIOUS DISEASES LABORATORY Test DIRECTORY contains information that is current as of February 18, 2022. All information contained herein is subject to change. For the most current test information, please view the CDC's INFECTIOUS DISEASES LABORATORY Test DIRECTORY on: Test OrderAcanthamoeba Molecular DetectionCDC-10471 Synonym(s)Free-living ameba, parasite, Acanthamoeba, granulomatous amebic encephalitis (GAE), keratitisCDC Pre-Approval NeededJennifer Cope(404) Ali(404) Information RequiredProvide the following information: history of present illness, exposure history, past medical history, treatment history, CSF results, imaging results. Available images can be submitted for preliminary morphological diagnosis, prior to submitting specimen for molecular identification.
Specimen Labeling This test order can accommodate diagnostic and non-diagnostic specimens. Testing subject to CLIA regulations requires two primary patient identifiers (e.g., patient first and last name, date of birth, unique patient identifier from time of collection, such as medical record number) on the specimen container and on the
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: